OXAPEX Trademark

Trademark Overview


On Thursday, February 1, 2018, a trademark application was filed for OXAPEX with the United States Patent and Trademark Office. The USPTO has given the OXAPEX trademark a serial number of 87780721. The federal status of this trademark filing is REGISTERED as of Tuesday, August 2, 2022. This trademark is owned by Hong Kong Cytogenetics and Medical Genetics Centre Limited. The OXAPEX trademark is filed in the Pharmaceutical Products category with the following description:

Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, namely, sterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; biological preparations for medical and veterinary purposes, namely, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synt...
oxapex

General Information


Serial Number87780721
Word MarkOXAPEX
Filing DateThursday, February 1, 2018
Status700 - REGISTERED
Status DateTuesday, August 2, 2022
Registration Number6805731
Registration DateTuesday, August 2, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 17, 2022

Trademark Statements


Description of MarkThe mark consists of stylized characters of "OXAPEX" with the letter "A" replaced with the Greek letter alpha.
Goods and ServicesHuman and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorders, tissue hypoxia, shock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; biological preparations for medical and veterinary purposes, namely, sterile solutions for use in oxygen therapeutics for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; biological preparations for medical and veterinary purposes, namely, hemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases; Biological preparations for medical and veterinary purposes, namely, protein arrays, biological tissue cultures, blood, blood plasma, and blood serums for the treatment of cardiovascular disorders, tissue hypoxia, shock, anemia, Gastrointestinal and Hepatobiliary System disease, Cardiovascular and Hematopoietic System diseases, Respiratory System diseases, Central Nervous System diseases, Musculo-Skeletal System diseases, Hormones related diseases, Oncology diseases, Genito-Urinary System diseases, Endocrine and Metabolic System diseases, Eye diseases, Ear and Mouth or Throat diseases, Skin diseases, Allergy and Immune System diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFIRST GAIN INTERNATIONAL LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHong Kong N/A
HK

Party NameFIRST GAIN INTERNATIONAL LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHong Kong N/A
HK

Party NameFIRST GAIN INTERNATIONAL LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressSHEUNG WAN
HK

Party NameHong Kong Cytogenetics and Medical Genetics Centre Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHong Kong N/A
HK

Trademark Events


Event DateEvent Description
Tuesday, August 2, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 2, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 8, 2022NOTICE OF ALLOWANCE CANCELLED
Monday, April 4, 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Monday, April 4, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, March 28, 2022TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY
Thursday, March 24, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 24, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 24, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 9, 2022PETITION INQUIRY LETTER ISSUED
Monday, March 7, 2022ASSIGNED TO PETITION STAFF
Friday, February 25, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 17, 2022SOU EXTENSION 5 GRANTED
Thursday, February 10, 2022SOU EXTENSION 5 FILED
Thursday, February 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 10, 2022TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 4 GRANTED
Monday, August 23, 2021SOU EXTENSION 4 FILED
Monday, August 23, 2021TEAS EXTENSION RECEIVED
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2021SOU EXTENSION 3 GRANTED
Thursday, February 18, 2021SOU EXTENSION 3 FILED
Thursday, February 18, 2021TEAS EXTENSION RECEIVED
Saturday, August 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 13, 2020SOU EXTENSION 2 GRANTED
Thursday, August 13, 2020SOU EXTENSION 2 FILED
Thursday, August 13, 2020TEAS EXTENSION RECEIVED
Thursday, February 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 25, 2020SOU EXTENSION 1 FILED
Tuesday, February 25, 2020TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 6, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 6, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, June 6, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 6, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, June 6, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, May 30, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 20, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 20, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, November 20, 2018SUSPENSION LETTER WRITTEN
Monday, November 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 15, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 15, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 15, 2018ASSIGNED TO EXAMINER
Wednesday, March 7, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 5, 2018ASSIGNED TO LIE
Tuesday, February 20, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 13, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, February 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 5, 2018NEW APPLICATION ENTERED IN TRAM